S. M. Herrmann, S. Sethi, and F. C. Fervenza, Membranous nephropathy: the start of a paradigm shift, Curr Opin Nephrol Hypertens, vol.21, issue.2, pp.203-213, 2012.

P. Callard and M. Colombat, Glomérulonéphrites extra-membraneuses in

L. H. Noel, Atlas de pathologie rénale, Médecine-Sciences Flammarion Paris, pp.165-180, 2008.

L. H. Beck and D. J. Salant, Membranous nephropathy: recent travels and new roads ahead, Kidney Int, vol.77, issue.9, pp.765-70, 2010.

P. Ronco and H. Debiec, Pathophysiological advances in membranous nephropathy: time for a shift in patient's care, Lancet, vol.385, issue.9981, pp.1983-92, 2015.

L. H. Beck, R. Bonegio, and G. Lambeau, M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy, N Engl J Med, vol.361, issue.1, pp.11-21, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00417718

J. F. Augusto, J. F. Subra, and A. Chevailler, Apport de l'immunologie au diagnostic en néphrologie : actualités en 2012. Revue Francophone des Laboratoires, vol.444, pp.95-96, 2012.

N. M. Tomas, L. H. Beck, and C. Meyer-schwesinger, Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy, N Engl J Med, vol.371, issue.24, pp.2277-87, 2014.

N. M. Tomas, E. Hoxha, and A. T. Reinicke, Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy, J Clin Invest, vol.126, issue.7, pp.2519-2551, 2016.

A. Behnert, M. Schiffer, and J. Müller-deile, Antiphospholipase A2 receptor autoantibodies: a comparison of three different immunoassays for the diagnosis of idiopathic membranous nephropathy, J Immunol Res, p.143274, 2014.

R. J. Glassock, Antiphospholipase A2 receptor autoantibody guided diagnosis and treatment of membranous nephropathy: a new personalized medical approach, Clin J Am Soc Nephrol, vol.9, issue.8, pp.1341-1344, 2014.

A. S. De-vriese, R. J. Glassock, and K. A. Nath, A Proposal for a Serology-Based Approach to Membranous Nephropathy, J Am Soc Nephrol, vol.28, issue.2, pp.421-430, 2017.

P. Ronco and H. Debiec, Anti-phospholipase A2 receptor antibodies and the pathogenesis of membranous nephropathy, Nephron Clin Pract, vol.128, issue.3-4, pp.232-239, 2014.

K. Hanasaki, Mammalian phospholipase A2: phospholipase A2 receptor, Biol Pharm Bull, vol.27, issue.8, pp.1165-1172, 2004.

D. C. Cattran and P. E. Brenchley, Membranous nephropathy: integrating basic science into improved clinical management, Kidney Int, vol.91, issue.3, pp.566-574, 2017.

B. Obrisca, G. Ismail, and R. Jurubita, Antiphospholipase A2 Receptor Autoantibodies: A Step Forward in the Management of Primary Membranous Nephropathy, Biomed Res Int, p.249740, 2015.

Y. H. Liu, C. H. Chen, and S. Y. Chen, Association of phospholipase A2 receptor 1 polymorphisms with idiopathic membranous nephropathy in Chinese patients in Taiwan, J Biomed Sci, vol.17, p.81, 2010.

H. C. Stanescu, M. Arcos-burgos, and A. Medlar, Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy, N Engl J Med, vol.364, issue.7, pp.616-642, 2011.

J. M. Hofstra and J. F. Wetzels, Anti-PLA 2R antibodies in membranous nephropathy: ready for routine clinical practice ?, Neth J Med, vol.70, issue.3, pp.109-122, 2012.

E. Hoxha, L. H. Beck, and T. Wiech, An Indirect Immunofluorescence Method Facilitates Detection of Thrombospondin Type 1 Domain-Containing 7A-Specific Antibodies in Membranous Nephropathy, J Am Soc Nephrol, vol.28, issue.2, pp.520-531, 2017.

Y. Du, J. Li, and F. He, The diagnosis accuracy of PLA2R-AB in the diagnosis of idiopathic membranous nephropathy: a meta-analysis

H. Dai, H. Zhang, and Y. He, Diagnostic accuracy of PLA2R autoantibodies and glomerular staining for the differentiation of idiopathic and secondary membranous nephropathy: an updated meta-analysis. Sci Rep, vol.5, p.8803, 2015.

B. Svobodova, E. Honsova, and P. Ronco, Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy, Nephrol Dial Transplant, vol.28, issue.7, pp.1839-1883, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00919114

Q. Xie, Y. Li, J. Xue, and Z. Xiong, Renal phospholipase A2 receptor in hepatitis B virus-associated membranous nephropathy, Am J Nephrol, vol.41, issue.4-5, pp.345-53, 2015.

T. Iwakura, N. Ohashi, and A. Kato, Prevalence of Enhanced Granular Expression of Thrombospondin Type-1 Domain-Containing 7A in the Glomeruli of Japanese Patients with Idiopathic Membranous Nephropathy, PLoS One, vol.10, issue.9, p.138841, 2015.

E. Hoxha, T. Wiech, and P. R. Stahl, A Mechanism for Cancer-Associated Membranous Nephropathy, N Engl J Med, vol.374, issue.20, pp.1995-2001, 2016.

C. P. Larsen, L. N. Cossey, and L. H. Beck, THSD7A staining of membranous glomerulopathy in clinical practice reveals cases with dual autoantibody positivity, Mod Pathol, vol.29, issue.4, pp.421-427, 2016.

S. Surindran, R. Ayalon, and N. Hasan, Coexistence of ANCAassociated glomerulonephritis and anti-phospholipase A(2) receptor antibody-positive membranous nephropathy, Clin Kidney J, vol.5, issue.2, pp.162-165, 2012.

T. Alfaadhel and D. Cattran, Management of Membranous Nephropathy in Western Countries, vol.1, pp.126-163, 2015.

. Glomerulonephritis-work-group, KDIGO Clinical Practice Guideline for Glomérulonephritis, Kidney Int Suppl, vol.2, pp.139-274, 2012.

S. Whittingham and I. R. Mackay, The iceberg analogy of autoimmunity, Postgrad Med J, vol.48, issue.556, pp.95-102, 1972.

M. J. Guerry, P. Vanhille, and P. Ronco, Serum anti-PLA2R antibodies may be present before clinical manifestations of membranous nephropathy, Kidney Int, vol.89, issue.6, p.1399, 2016.

L. Kao, V. Lam, and M. Waldman, Identification of the immunodominant epitope region in phospholipase A2 receptor-mediating autoantibody binding in idiopathic membranous nephropathy, J Am Soc Nephrol, vol.26, issue.2, pp.291-301, 2015.

M. Fresquet, T. A. Jowitt, and J. Gummadova, Identification of a major epitope recognized by PLA2R autoantibodies in primary membranous nephropathy, J Am Soc Nephrol, vol.26, issue.2, pp.302-315, 2015.

B. Seitz-polski, G. Dolla, and C. Payré, Epitope Spreading of Autoantibody Response to PLA2R Associates with Poor Prognosis in Membranous Nephropathy, J Am Soc Nephrol, vol.27, issue.5, pp.1517-1550, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01455661

D. A. Kanigicherla, C. D. Short, and S. A. Roberts, Long-term outcomes of persistent disease and relapse in primary membranous nephropathy, Nephrol Dial Transplant, vol.31, issue.12, pp.2108-2114, 2016.

A. P. Bech, J. M. Hofstra, and P. E. Brenchley, Association of anti-PLA2R antibodies with outcomes after immunosuppressive therapy in idiopathic membranous nephropathy, Clin J Am Soc Nephrol, vol.9, issue.8, pp.1386-92, 2014.

J. Müller-deile, L. Schiffer, M. Hiss, H. Haller, and M. Schiffer, A new rescue regimen with plasma exchange and rituximab in high-risk membranous glomerulonephritis, Eur J Clin Invest, vol.45, issue.12, pp.1260-1269, 2015.